Gain Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Gain Therapeutics

10/08/2023 14:32

* Gain Therapeutics Inc  GANX.OQ  reported a quarterly
adjusted
loss of 62 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 31 cents per share.
    * Reported revenue was zero​; analysts expected $1.01
million. 
    * Gain Therapeutics Inc's reported EPS for the quarter was a
loss
of 62 cents​.
    * The mean earnings estimate of analysts had risen by
about 19.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Gain Therapeutics Inc shares had fallen by 16.3% this
quarter and gained 19.8% so far this year.
    * The company reported a quarterly loss of $7.69 million.
    * Wall Street's median 12-month price target for Gain
Therapeutics
Inc is $10.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.31          -0.62          Missed
 Mar. 31 2023      -0.39          -0.43          Missed
 Dec. 31 2022      -0.38          -0.39          Missed
 Sep. 30 2022      -0.46          -0.38          Beat